DaShenLin Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 4/6
DaShenLin Pharmaceutical Group has a total shareholder equity of CN¥8.1B and total debt of CN¥4.5B, which brings its debt-to-equity ratio to 55.8%. Its total assets and total liabilities are CN¥25.9B and CN¥17.8B respectively. DaShenLin Pharmaceutical Group's EBIT is CN¥1.4B making its interest coverage ratio 9. It has cash and short-term investments of CN¥5.7B.
Key information
55.8%
Debt to equity ratio
CN¥4.54b
Debt
| Interest coverage ratio | 9x |
| Cash | CN¥5.72b |
| Equity | CN¥8.13b |
| Total liabilities | CN¥17.75b |
| Total assets | CN¥25.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603233's short term assets (CN¥12.1B) do not cover its short term liabilities (CN¥13.2B).
Long Term Liabilities: 603233's short term assets (CN¥12.1B) exceed its long term liabilities (CN¥4.6B).
Debt to Equity History and Analysis
Debt Level: 603233 has more cash than its total debt.
Reducing Debt: 603233's debt to equity ratio has increased from 28.8% to 55.8% over the past 5 years.
Debt Coverage: 603233's debt is well covered by operating cash flow (70.6%).
Interest Coverage: 603233's interest payments on its debt are well covered by EBIT (9x coverage).